About Blue Horizon Biotech
Blue Horizon Biotech is a company based in United States founded in 2020. It operates as a B2B. Blue Horizon Biotech operates in a competitive market with competitors including ImpriMed, VetDC, CanFel Therapeutics, Animal Life Sciences and Vetco Pharmaceuticals, among others.
- Headquarter United States
- SectorsHealthcare
- Website bluehorizonbiotech.com
Competitors of Blue Horizon Biotech
Blue Horizon Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImpriMed, VetDC, CanFel Therapeutics, Animal Life Sciences and Vetco Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imprimedicine.com | 2017 | Palo Alto, United States | $34.92M | 14 | Provider of precision medicines for veterinary cancer | |
| vet-dc.com | 2010 | Fort Collins, United States | $5.49M | – | Anticancer therapies for animals are developed by VetDC. | |
| canfeltherapeutics.com | 1999 | Torrance, United States | – | – | Cancer therapeutics for animals are developed using innovative platforms. | |
| animallifesciences.com | 2018 | New York, United States | $198,800 | – | Developer of pet food, supplements and therapeutics to treat cancer in animals | |
| vetcogroup.com | 2012 | Sanchong, Taiwan | – | – | Offers comprehensive pharmaceutical products for treating cancer in animals. |
Detailed competitors of Blue Horizon Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Blue Horizon Biotech
10 companies that operate in the same segment as Blue Horizon Biotech (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Blue Horizon Biotech
Blue Horizon Biotech was founded in 2020.
Blue Horizon Biotech is headquartered in United States.
Blue Horizon Biotech develops innovative veterinary therapeutics for cancer treatment, focusing on providing healthcare solutions, advancing biotech innovations, veterinary medicine, and cancer therapeutics. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Blue Horizon Biotech's top competitors include ImpriMed, VetDC and Animal Life Sciences.